Last update 23 Jan 2025
Emeriti Bio AB

Emeriti Bio AB

Private Company|
2015|
Sweden
|
www.emeritibio.se

Overview

Tags

Cardiovascular Diseases
Respiratory Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
AT2R(Angiotensin II receptor type 2)1
HDACs(Histone deacetylase)1

Related

2
Drugs associated with Emeriti Bio AB
Buloxibutid
Target
AT2R
Mechanism
AT2R agonists
Active Org.
Vicore Pharma ABVicore Pharma AB [+2]
Originator Org.
Vicore Pharma Holding AB
Active Indication
COVID-19 [+4]
Inactive Indication
Retinitis Pigmentosa [+1]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
CS-014
Target
HDACs
Mechanism
HDAC inhibitors
Active Org.
Cereno Scientific ABCereno Scientific AB [+1]
Originator Org.
Emeriti Bio ABEmeriti Bio AB
Active Indication
Idiopathic Pulmonary Fibrosis [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Emeriti Bio AB
Login to view more data
0 Patents (Medical) associated with Emeriti Bio AB
Login to view more data
100 Deals associated with Emeriti Bio AB
Login to view more data
100 Translational Medicine associated with Emeriti Bio AB
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Buloxibutid
 ( AT2R )		Idiopathic Pulmonary Fibrosis
More
Clinical
CS-014
 ( HDACs )		Cardiovascular Diseases
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free